TRACON Pharmaceuticals, Inc. (NASDAQ:TCON – Get Free Report) saw a large growth in short interest in December. As of December 31st, there was short interest totalling 1,790,000 shares, a growth of 178.9% from the December 15th total of 641,900 shares. Based on an average daily trading volume, of 5,040,000 shares, the short-interest ratio is presently […]
StockNews.com assumed coverage on shares of TRACON Pharmaceuticals (NASDAQ:TCON – Free Report) in a research note published on Tuesday. The firm issued a hold rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reaffirmed a buy rating and set a $7.00 price objective on shares of TRACON Pharmaceuticals in a research report on Monday, November […]
StockNews.com assumed coverage on shares of TRACON Pharmaceuticals (NASDAQ:TCON – Free Report) in a research note released on Monday. The firm issued a hold rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reiterated a buy rating and issued a $7.00 price objective on shares of TRACON Pharmaceuticals in a research report on Monday, November […]
StockNews.com initiated coverage on shares of TRACON Pharmaceuticals (NASDAQ:TCON – Free Report) in a report released on Monday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reiterated a buy rating and issued a $7.00 price objective on shares of TRACON Pharmaceuticals in a research note on Monday, November […]
StockNews.com began coverage on shares of TRACON Pharmaceuticals (NASDAQ:TCON – Free Report) in a report released on Monday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reiterated a buy rating and set a $7.00 price target on shares of TRACON Pharmaceuticals in a report on Monday, November 20th. […]